Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0001209191-23-022695

EVP, Cell & Genetic Therapies gave up 1,466 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Sanna Bastiano · EVP, Cell & Genetic Therapies

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-03-31 Shares withheld for taxes : show line 1 in the form −1,466 $313.74 $459,943 47,802 D
Loading xslF345X04/doc4.xml…